|
ZNF514 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.079000E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.894100E-02 |
| Normal-vs-Stage2 |
1.852030E-01 |
| Normal-vs-Stage3 |
7.254800E-01 |
| Normal-vs-Stage4 |
8.025600E-01 |
| Stage1-vs-Stage2 |
5.291200E-01 |
| Stage1-vs-Stage3 |
7.056400E-02 |
| Stage1-vs-Stage4 |
7.290600E-01 |
| Stage2-vs-Stage3 |
1.508150E-01 |
| Stage2-vs-Stage4 |
5.089200E-01 |
| Stage3-vs-Stage4 |
7.073000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.660680E-03 |
| Normal-vs-AfricanAmerican |
2.524400E-01 |
| Normal-vs-Asian |
3.946600E-01 |
| Caucasian-vs-AfricanAmerican |
2.043000E-01 |
| Caucasian-vs-Asian |
6.562800E-03 |
| AfricanAmerican-vs-Asian |
6.012100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.042210E-02 |
| Normal-vs-Female |
9.176000E-03 |
| Male-vs-Female |
3.776600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.245960E-01 |
| Normal-vs-Extreme_Weight |
1.725980E-01 |
| Normal-vs-Obese |
2.456100E-02 |
| Normal-vs-Extreme_Obese |
1.381770E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.406800E-01 |
| Normal_Weight-vs-Obese |
5.363200E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.300600E-01 |
| Extreme_Weight-vs-Obese |
2.327200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.060800E-01 |
| Obese-vs-Extreme_Obese |
6.602400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.291000E-01 |
| Normal-vs-Age(41-60Yrs) |
2.570100E-04 |
| Normal-vs-Age(61-80Yrs) |
7.090300E-02 |
| Normal-vs-Age(81-100Yrs) |
8.328000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.493250E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.515000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.274200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.787820E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.329370E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.168800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.190400E-04 |
| Normal-VS-Type2 PRCC |
8.521400E-01 |
| Normal-VS-KIRP CIMP |
1.918200E-02 |
| Normal-VS-Unclassified PRCC |
3.044200E-02 |
| Type1 PRCC-VS-Type2 PRCC |
3.8714999999967E-05 |
| Type1 PRCC-VS-KIRP CIMP |
1.813770E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
9.476600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.104400E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.204000E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
7.439600E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.010200E-01 |
| Normal-vs-N1 |
2.342600E-01 |
| Normal-vs-N2 |
4.029600E-01 |
| N0-vs-N1 |
3.131800E-01 |
| N0-vs-N2 |
3.668800E-01 |
| N1-vs-N2 |
3.742600E-01 |
|
|
